Ortin Global P/B Ratio
Ortin Global (ORTINGLOBE) P/B ratio is 11.82 (High), book value per share ₹2.50 vs Healthcare average P/B of -0.33 — Very High - Significant premium, high growth expectations or speculative. Review ORTINGLOBE P/E ratio to evaluate earnings-based valuation against sector peers.
Current Valuation Metrics
Book Value Breakdown (2025)
Valuation Signal
Sector Context
ORTINGLOBE P/B Ratio — Valuation Insights & Book Value Analysis
Ortin Global price-to-book ratio interpretation, valuation status and historical context — current P/B 11.82 (High). For live price, earnings yield and the full fundamental profile, see Ortin Global share price screener.
- Stock appears overvalued with PB of 11.82, trading at significant premium to book value
- Trading at high premium to book value - indicates strong growth expectations or asset-light business model
- Current PB is 253.7% above historical average
- Trading at premium to sector average PB of -0.33
Ortin Global P/B Ratio Historical Trend
ORTINGLOBE annual price-to-book ratio — 5 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. View Ortin Global yearly highs lows for the annual high/low range and current price position.
ORTINGLOBE Historical P/B Ratio — Book Value Per Share & Year-End Price
Ortin Global annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2025 | 6.16 | ₹2.5 | ₹15.41 | ₹2 | High |
| 2024 | 4.77 | ₹3.75 | ₹17.90 | ₹3 | High |
| 2023 | 1.67 | ₹13.75 | ₹23.02 | ₹11 | Moderate |
| 2022 | 1.72 | ₹13.75 | ₹23.70 | ₹11 | Moderate |
| 2021 | 2.39 | ₹13.75 | ₹32.90 | ₹11 | Moderate |
ORTINGLOBE vs Healthcare Peers — P/B Ratio Comparison
Ortin Global P/B 11.82 vs Healthcare average -0.33, median 0.6 — range -17.45–1.1.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Rekvina Laboratories | VINRKLB | -17.45 | ₹21 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Parmax Pharma | PARMAX | -4.18 | ₹29 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -2.23 | ₹73 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.79 | ₹126 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |
| Vivimed Labs | VIVIMEDLAB | -0.56 | ₹50 | Low |